430 likes | 543 Vues
This document provides an in-depth overview of Critical Limb Ischemia (CLI), focusing on its prevalence, clinical presentation, pathophysiology, and treatment options. It highlights the significant impact of Peripheral Arterial Disease on millions of Americans and details the acute and chronic manifestations of CLI, including rest pain and gangrene. Emphasis is placed on the importance of timely intervention to reduce mortality and morbidity. The document also outlines diagnostic testing, treatment goals, and post-operative care, aiming to educate healthcare providers and enhance patient outcomes.
E N D
Northside Cherokee 2nd Annual CV Summit Scott R. Beach, MD FACC
Peripheral Arterial Disease • Affects over 8 million Americans • Affects 12% of the general population and 20% of those > 70 years old • Prevalence continues to increase as baby boomer generation ages
Critical Limb Ischemia • Subset of PVD patients • Prevelance is 1-2% of patients with PVD over the age of 50
Critical Limb Ischemia • Blood flow is insufficient to meet tissue oxygen demands • Ischemic injury occurs in tissues with the least blood supply and results in necrosis • Local and systemic inflammatory response • Compensatory mechanisms: post stenotic arteriolar vasodilatation collateral circulation
Critical Limb Ischemia • Acute ischemia – sudden decrease is blood flow that causes a potential threat to limb viability – rest pain, ischemic ulcers, and/or gangrene who present w/i 2 weeks of event • Chronic ischemia – similar manifestations as actue ischemia but > 2 weeks.
Critical Limb Ischemia • Mortality approaches 25% at 1 year after diagnosis • Additional 25% require major amputation • Amputation increases morbidity and mortality – 50% mortality at 5 years • Only 65% BKA amputees ambulatory 1 yr • Only 29% AKA amputees ambulatory 1 yr
Rutherford Classification • Stage 0 – Asymptomatic • Stage 1 – Mild Claudication • Stage 2 – Moderate Claudication • Stage 3 – Severe Claudication • Stage 4 – Rest Pain • Stage 5 – Ischemic ulceration not exceeding the digits of the foot • Stage 6 – Severe Ischemic ulcers or gangrene
Pathophysiology • Usually seen when two or more levels of the distal arterial tree has a significant stenosis or occlusion. • Multi level disease promotes severe ischemia by reducing the effectiveness of collateral flow and lower distal systolic driving pressures
CLI treatment goals Pain Relief Heal Wounds Promote / Protect Mobility Save a LIMB Save a Life
Clinical Presentation of CLI • Rest Pain - Pain in foot usually when limb is elevated and relieved with dependency • Ulceration – Distal areas of extremities such as tip of toes, severe pain, dry, poor vascularity • Gangrene – Devitalized tissue
Avoid at all Cost! BKA patient has 50% mortality at 5 years Estimated > 50% increase in energy expenditure in order to Ambulate after BKA
Interventional Options • Angiogram required to formulate “game plan” • Must evaluate inflow and outflow, usually multi-level disease • Treat inflow lesions first • Must optimize risk factors and anti platelet therapies
Equipment : Basic Needs • Sheaths • Guidewires • Crossing catheters • PTA balloons • Stents • Re-entry devices • Athrectomy devices
Tibial Interventions • Retrograde • Antegrade • Crossing the lesion • Pedal access • Use of CTO devices • Subintimal vs intraluminal approach
Economics of Limb Salvage • Limb salvage revascularization is expensive, but better than the alternative of primary amputation.
Critical Limb Ischemia • 1-year mortality for patients with CLI is 25% (mainly cardiac events) • The economic burden is high for patients with CLI • The median cost of medical care for a patient following an amputation is estimated to be twice that of a successful limb salvage
Goals of endovascular treatment • Increase tissue perfusion • Provide blood flow to affected area to faciliate healing • Achieve resolution of rest pain and gangrene • Improve patient function • Prevent limb loss
Diagnostic Testing • ABI/ PVR • Ultrasound • CTA/ MRA – good for inflow but bad for outflow • Angiogram – provides most accurate road map for developing a plan for each individual
Advantages of Endovascular Treatment • Minimally invasive • Avoidance of general anesthesia • Minimal risk of wound infection • Minimal recovery time • Minimal hospital stay, many going home the same day
Good News Goodney, JVS 2009; 50:54-60
Revascularization Trends Geraghty et al MVSS 2005
Post revascularization plan • Check distal pulses • Evaluate for possible complications of revascularization both endovascular and surgical • Patient education
Post Operative Period • Graft occlusion – acute rest pain may be initial presentation, or sudden motor loss/ limb weakness • Surigcal incisions – must be kept clean and dry. Observe for signs of infection (cellulitis, elevated WBC, drainage) • Lymphatic injury – clear, pale yellow drainage, lymphocele
Post operative • Hematoma • Pseudoaneurysm • Sphenous neuropathy – pain along the medial aspect of the lower part of the thigh and leg, usually resolves in 3-6 months
Foot care • Alleviate heel pressure • No bare feet! • Apply lubricating cream to legs and feet • Gangrenous lesions must be kept clean and dry • Avoid heating pads, cold packs, and any adhesives
Take home message • For patients who present with CLI, it is imperative to move quickly and consult an endovascular specalist • Positive outcomes require the cohesive team of endovascular specialists, podiatry, wound care, infectious disease specalists, and primary care physicians.